Eli Estey
Impact in
- Hematology top 1%
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
- Hematopoietic Stem Cell Transplantation
- Genetics top 5%
- Myeloproliferative Neoplasms: Diagnosis and Treatment
- Chronic Lymphocytic Leukemia Research
Papers in
-
- Acute Myeloid Leukemia Research 9
- Hematopoietic Stem Cell Transplantation 3
-
- Retinoids in leukemia and cellular processes 2
- Histone Deacetylase Inhibitors Research 1
- Co-authors
- Jennifer Clark (1 shared paper)Stephen D. Nimer (1 shared paper)David Lebwohl (1 shared paper)Pamela Cohen (1 shared paper)D. Gary Gilliland (1 shared paper)James D. Griffin (1 shared paper)Wilson Grandin (1 shared paper)Virginia M. Klimek (1 shared paper)
- Journals
- Leukemia Research (2 papers)Drugs (1 paper)Frontiers in Oncology (1 paper)Leukemia (1 paper)Nature Reviews Disease Primers (1 paper)
- Partner nations
- United StatesUnited KingdomNetherlands
In The Last Decade
Eli Estey
10 papers receiving 973 citations
Eli Estey's Hit Papers
Peers
Comparison fields: 5 of 61
- Hematology 782
- Genetics 247
- Molecular Biology 480
- Cancer Research 85
- Public Health, Environmental and Occupational Health 161
Countries citing papers authored by Eli Estey
This map shows the geographic impact of Eli Estey's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Eli Estey with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Eli Estey more than expected).
Fields of papers citing papers by Eli Estey
This network shows the impact of papers produced by Eli Estey. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Eli Estey. The network helps show where Eli Estey may publish in the future.
Co-authors
The 25 scholars most cited alongside Eli Estey, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
| # | Work | ||
|---|---|---|---|
| 1 | Patients with acute myeloid leukemia and an activating mutation in FLT3 respond to a small-molecule FLT3 tyrosine kinase inhibitor, PKC412 Hit paper breakdown → | 2004 | 528 |
| 2 | Acute myeloid leukaemia Hit paper breakdown → | 2016 | 289 |
| 3 | 2010 | 103 | |
| 4 | 1994 | 21 | |
| 5 | 2013 | 17 | |
| 6 | 2020 | 15 | |
| 7 | Management of myelodysplastic syndromes: 2008 update. | 2008 | 9 |
| 8 | 2018 | 8 | |
| 9 | 2013 | 5 | |
| 10 | 2011 | 1 |
About Eli Estey
Eli Estey is a scholar working on Hematology, Molecular Biology, Genetics, Pulmonary and Respiratory Medicine and Public Health, Environmental and Occupational Health, having authored 10 papers that have together received 996 indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (9 papers), Chronic Lymphocytic Leukemia Research (3 papers), Hematopoietic Stem Cell Transplantation (3 papers), Acute Lymphoblastic Leukemia research (2 papers), Retinoids in leukemia and cellular processes (2 papers), Lymphoma Diagnosis and Treatment (1 paper), Histone Deacetylase Inhibitors Research (1 paper) and Neonatal Health and Biochemistry (1 paper). The work is most often cited by research in Hematology (782 citations), Genetics (247 citations), Molecular Biology (480 citations), Cancer Research (85 citations) and Public Health, Environmental and Occupational Health (161 citations). Eli Estey has collaborated with scholars based in United States, United Kingdom and Netherlands. Frequent co-authors include Jennifer Clark, Stephen D. Nimer, David Lebwohl, Pamela Cohen, D. Gary Gilliland, James D. Griffin, Wilson Grandin, Virginia M. Klimek, Daniel J. DeAngelo and Ilene Galinsky. Their work appears in journals such as Leukemia Research, Drugs, Frontiers in Oncology, Leukemia and Nature Reviews Disease Primers.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.